| Serial Number | 79379393 |
| Word Mark | NDURE |
| Filing Date | Wednesday, April 19, 2023 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, August 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations; biological preparations for medical purposes; diagnostic preparations and materials; therapeutic preparations and substances; anti-angiogenesis preparations; anti-cancer preparations; anti-inflammatory preparations; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, physiological disorders, hormonal disorders, inherited disease, single gene disorders, respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, immuno-deficiencies, organ damage, cell proliferation, peripheral neurological disorders, genitourinary disorders, musculoskeletal disorders, and blood disorders; diagnostic reagents for medical use; DNA, antibodies and proteins for medical use; DNA and/or antibodies and/or proteins that stimulate cells for medical use; DNA, antibodies and proteins for therapeutic use; diagnostic products and reagents for medical use |
| Pseudo Mark | ENDURE |
| Goods and Services | Medical and pharmacological research services; scientific and technological services and research and design relating thereto; scientific research for medical purposes; pharmaceutical research and development services; pharmaceutical testing; research and development in the biotechnology field; research and development services in the field of antibodies; biotechnology services; conducting clinical trials; biological research, clinical research and medical research; providing information about the results of clinical trials for pharmaceutical products; analytic and diagnostic research and laboratory services in the field of science; development of assays, both for products and analysis, provided for others; laboratory services; research and development of new products for others; research and scientific analysis relating to drug discovery, as well as development thereof for others; scientific advisory services; scientific consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; issuing of scientific information; advisory services relating to scientific and clinical research; provision of information and consultancy in relation to the aforesaid services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 29, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 29, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Elasmogen Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, September 28, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 29, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 3, 2023 | APPLICATION FILING RECEIPT MAILED |
| Saturday, November 11, 2023 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Wednesday, January 17, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, January 2, 2024 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Wednesday, January 17, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, January 18, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, January 19, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, February 5, 2024 | REFUSAL PROCESSED BY MPU |
| Thursday, January 18, 2024 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Thursday, January 18, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, February 27, 2024 | REFUSAL PROCESSED BY IB |
| Monday, August 19, 2024 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Tuesday, April 8, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, February 5, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, August 19, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, June 20, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, April 8, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |